Manuel Humberto Cháirez-Ramírez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Manuel Humberto Cháirez-Ramírez has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Rubén Francisco González-Laredo
Instituto Tecnológico de Durango
8 shared publications - Nuria Elizabeth Rocha-Guzmán
Tecnológico Nacional de México/Instituto Tecnológico de Durango. Blvd. Felipe Pescador 1830 Ote., Durango 34080, Mexico
5 shared publications - José Alberto Gallegos-Infante
Tecnológico Nacional de México/Instituto Tecnológico de Durango, Laboratorio Nacional Conacyt-LaNAEPBi, Blvd. Felipe Pescador 1830 Ote., C.P. 34080 Durango, Dgo. México
3 shared publications J.A. Sánchez-Burgos
2 shared publications- Luis Medina-Torres
Universidad Nacional Autónoma de México
2 shared publications M.R. Moreno-Jiménez
2 shared publications
Latest Publications
- 20 February 2026
- Published by Springer Nature
- p. 83-117
Bioaccumulation, Biomagnification and Public Health: Impact of Toxic Waste in the Food Chain
- 20 February 2026
- Published by Springer Nature
- p. 83-117
Bioaccumulation, Biomagnification and Public Health: Impact of Toxic Waste in the Food Chain
- Open Access
- 1 August 2025
- Published by Forschungsgesellschaft für Arbeitsphysiologie und Arbeitsschutz e.V. in EXCLI Journal
- Vol. 24, 957-991
Polyphenols bind G4-Quadruplex structures and act as epigenetic modifiers with anti-cancer effects
G4-quadruplexes (G4s) are non-canonical structures of nucleic acids that develop in guanine rich regions of DNA and RNA. Due to their presence in oncogenic promoters and telomeres, G4s represent attractive targets in anti-cancer drug designs. G4s have also been the subject of recent research regarding their role as epigenetic modulators, supporting their participation in epigenetic processes that control gene expression. The development of small compounds that preferentially target G4s have led to a better understanding of how G4s control these mechanisms. Natural products have greatly contributed to the development of many successful examples of compounds with excellent anticancer activities. Therefore, it is important to investigate ligands targeting G4-quadruplexes in naturalproducts such as dietary polyphenols and their derivatives. In this review, we provide an overview of the latest research on natural compounds, with especial emphasis on dietary polyphenols, as G4-quadruplex targeted ligands. We also discuss dietary polyphenols’ structural chemistry that could facilitate their characterization as G4 ligands, highlighting their potential in the development of anticancer drugs. Finally, we explore polyphenols’ potential mechanisms of action in regulating epigenetic machinery through G4 binding, thereby providing insights for the development of safe and effective therapeutical tools against cancer.
- 1 August 2025
- Published by Forschungsgesellschaft für Arbeitsphysiologie und Arbeitsschutz e.V. in EXCLI Journal
- Vol. 24, 957-991
Open AccessPolyphenols bind G4-Quadruplex structures and act as epigenetic modifiers with anti-cancer effects
G4-quadruplexes (G4s) are non-canonical structures of nucleic acids that develop in guanine rich regions of DNA and RNA. Due to their presence in oncogenic promoters and telomeres, G4s represent attractive targets in anti-cancer drug designs. G4s have also been the subject of recent research regarding their role as epigenetic modulators, supporting their participation in epigenetic processes that control gene expression. The development of small compounds that preferentially target G4s have led to a better understanding of how G4s control these mechanisms. Natural products have greatly contributed to the development of many successful examples of compounds with excellent anticancer activities. Therefore, it is important to investigate ligands targeting G4-quadruplexes in naturalproducts such as dietary polyphenols and their derivatives. In this review, we provide an overview of the latest research on natural compounds, with especial emphasis on dietary polyphenols, as G4-quadruplex targeted ligands. We also discuss dietary polyphenols’ structural chemistry that could facilitate their characterization as G4 ligands, highlighting their potential in the development of anticancer drugs. Finally, we explore polyphenols’ potential mechanisms of action in regulating epigenetic machinery through G4 binding, thereby providing insights for the development of safe and effective therapeutical tools against cancer.
- Open Access
Rehydration Beverages Made from Quercus sideroxyla Infusion, Probiotics, and Prebiotics: Antioxidant and Anti-Inflammatory Potential
High rehydration beverage consumption represents a significant opportunity for the integration of biotic products that offer the potential to improve body composition and intestinal health. Quercus sideroxyla (IQS) infusions contain polyphenolic compounds with antioxidant and anti-inflammatory properties, and in combination with probiotic strains and prebiotic materials, they offer a promising alternative for generating designer beverages for physically active people. These beverages were formulated using a combination of IQS, agave fructooligosaccharides (FOS), microencapsulated probiotics of Akkermansia muciniphila and Bifidobacterium longum, electrolytes, and glucose. Stable microencapsulated probiotics were obtained by spray drying, using agave gums (PD > 10) and gum arabic as wall materials. The beverage formulations were generated with different percentages of FOS (A:1.6%, B:1.2%, and C:0.8%). The phenolic profile of the beverages was determined by LC-MS/MS, indicating a difference in the concentration of compounds, highlighting changes associated with the addition of FOS compared with IQS. Sensory analyses indicate a preference for the beverage with the highest FOS concentration. The antioxidant potential of the formulations, determined by ABTS, DPPH, and ORAC, showed no differences between the drinks; however, analyses indicate a positive correlation with quinic acid, t-cinnamic acid, quercetin 3-O-glucoside, and total phenolic content, suggesting a synergistic effect. The drinks with higher FOS content exhibited a higher anti-inflammatory potential (EMA). Therefore, it can be concluded that a rehydrating drink with a higher FOS content offers a prebiotic effect with potential anti-inflammatory activity and, according to the panelists, is a suitable drink for evaluating its effects on body composition and intestinal health in people who have recently started physical activity.
Open AccessRehydration Beverages Made from Quercus sideroxyla Infusion, Probiotics, and Prebiotics: Antioxidant and Anti-Inflammatory Potential
High rehydration beverage consumption represents a significant opportunity for the integration of biotic products that offer the potential to improve body composition and intestinal health. Quercus sideroxyla (IQS) infusions contain polyphenolic compounds with antioxidant and anti-inflammatory properties, and in combination with probiotic strains and prebiotic materials, they offer a promising alternative for generating designer beverages for physically active people. These beverages were formulated using a combination of IQS, agave fructooligosaccharides (FOS), microencapsulated probiotics of Akkermansia muciniphila and Bifidobacterium longum, electrolytes, and glucose. Stable microencapsulated probiotics were obtained by spray drying, using agave gums (PD > 10) and gum arabic as wall materials. The beverage formulations were generated with different percentages of FOS (A:1.6%, B:1.2%, and C:0.8%). The phenolic profile of the beverages was determined by LC-MS/MS, indicating a difference in the concentration of compounds, highlighting changes associated with the addition of FOS compared with IQS. Sensory analyses indicate a preference for the beverage with the highest FOS concentration. The antioxidant potential of the formulations, determined by ABTS, DPPH, and ORAC, showed no differences between the drinks; however, analyses indicate a positive correlation with quinic acid, t-cinnamic acid, quercetin 3-O-glucoside, and total phenolic content, suggesting a synergistic effect. The drinks with higher FOS content exhibited a higher anti-inflammatory potential (EMA). Therefore, it can be concluded that a rehydrating drink with a higher FOS content offers a prebiotic effect with potential anti-inflammatory activity and, according to the panelists, is a suitable drink for evaluating its effects on body composition and intestinal health in people who have recently started physical activity.
- 15 October 2024
- Published by Wiley in Polymer International
- Vol. 74 (6) , 483-493
Green polymer‐based materials as promising therapeutical agents for non‐communicable diseases
Polymers play a significant role in the modern world and have broad applications, particularly in medicine and pharmacology. However, polymer debris represents a significant environmental threat. Therefore, new materials with exceptional performance and environmental safety are needed. The circular economy has led to the development of ‘green polymers’ with enhanced renewability, biodegradability and compostability and properties similar to those of conventional polymers but with a significantly reduced carbon footprint. Green polymers have been extensively utilized in formulating diverse materials for medical purposes. Using green polymers for medical and pharmaceutical applications may improve outcomes for non‐communicable diseases by providing safer and more effective drug delivery systems, reducing side effects with improved biocompatibility and enhancing targeted disease treatments. Green polymer‐based materials can be engineered in various applications, making them particularly beneficial in managing chronic conditions like cancer, diabetes or cardiovascular diseases, where reliable and long‐term treatments are vital. Therefore, this review highlights the importance of a comprehensive understanding of green polymers as novel material sources for improving the treatment and control of non‐communicable diseases. © 2024 Society of Chemical Industry.
- 15 October 2024
- Published by Wiley in Polymer International
- Vol. 74 (6) , 483-493
Green polymer‐based materials as promising therapeutical agents for non‐communicable diseases
Polymers play a significant role in the modern world and have broad applications, particularly in medicine and pharmacology. However, polymer debris represents a significant environmental threat. Therefore, new materials with exceptional performance and environmental safety are needed. The circular economy has led to the development of ‘green polymers’ with enhanced renewability, biodegradability and compostability and properties similar to those of conventional polymers but with a significantly reduced carbon footprint. Green polymers have been extensively utilized in formulating diverse materials for medical purposes. Using green polymers for medical and pharmaceutical applications may improve outcomes for non‐communicable diseases by providing safer and more effective drug delivery systems, reducing side effects with improved biocompatibility and enhancing targeted disease treatments. Green polymer‐based materials can be engineered in various applications, making them particularly beneficial in managing chronic conditions like cancer, diabetes or cardiovascular diseases, where reliable and long‐term treatments are vital. Therefore, this review highlights the importance of a comprehensive understanding of green polymers as novel material sources for improving the treatment and control of non‐communicable diseases. © 2024 Society of Chemical Industry.
- 12 November 2018
- Published by Wiley in Biomedical Chromatography
- Vol. 33 (3) , e4432
Absorption and distribution of lupeol in CD‐1 mice evaluated by UPLC–APCI+–MS/MS
Lupeol is a dietary triterpene that shows limited water solubility, which affects its bioavailability. It is well known that poor oral bioavailability is one of the major causes of therapeutic variability. Lupeol has been reported to have multiple biological activities; however, there are no reports about its bioavailability. Therefore, the objective of this research was to evaluate the systemic bioavailability of lupeol. An experimental strategy with three groups of female CD‐1 strain mice was proposed (control, olive oil and lupeol in olive oil), at six experimental times (0.5, 2, 4, 8, 12 and 24 h) with four animals per experimental point. Mice were sacrificed for organs, urine, feces and blood collection. Lupeol was extracted from samples and analyzed by UPLC–APCI+–MS/MS, obtaining the pharmacokinetics parameters time to peak concentration 6.444 ± 0.851 h and peak concentration 8.071 ± 2.930 μg/mL. Study of direct digestion and absorption in various organs showed important concentrations of lupeol at earlier post‐administration times (stomach, 137.25 ± 19.94 ng/mg and small intestine, 99.00 ± 12.99 ng/mg). The main excretion route was fecal, with a peak at 12 h post‐administration (163.28 ± 9.83 μg/mg). Absorption of lupeol by the animals was better than expected despite its nonpolar nature (extent of absorption F = 0.645 ± 0.0581).
- 12 November 2018
- Published by Wiley in Biomedical Chromatography
- Vol. 33 (3) , e4432
Absorption and distribution of lupeol in CD‐1 mice evaluated by UPLC–APCI+–MS/MS
Lupeol is a dietary triterpene that shows limited water solubility, which affects its bioavailability. It is well known that poor oral bioavailability is one of the major causes of therapeutic variability. Lupeol has been reported to have multiple biological activities; however, there are no reports about its bioavailability. Therefore, the objective of this research was to evaluate the systemic bioavailability of lupeol. An experimental strategy with three groups of female CD‐1 strain mice was proposed (control, olive oil and lupeol in olive oil), at six experimental times (0.5, 2, 4, 8, 12 and 24 h) with four animals per experimental point. Mice were sacrificed for organs, urine, feces and blood collection. Lupeol was extracted from samples and analyzed by UPLC–APCI+–MS/MS, obtaining the pharmacokinetics parameters time to peak concentration 6.444 ± 0.851 h and peak concentration 8.071 ± 2.930 μg/mL. Study of direct digestion and absorption in various organs showed important concentrations of lupeol at earlier post‐administration times (stomach, 137.25 ± 19.94 ng/mg and small intestine, 99.00 ± 12.99 ng/mg). The main excretion route was fecal, with a peak at 12 h post‐administration (163.28 ± 9.83 μg/mg). Absorption of lupeol by the animals was better than expected despite its nonpolar nature (extent of absorption F = 0.645 ± 0.0581).
- 13 July 2017
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 30 (8) , 1562-1571
In Silico Prediction of the Toxic Potential of Lupeol
Lupeol is a natural triterpenoid found in many plant species such as mango. This compound is the principal active component of many traditional herbal medicines. In the past decade, a considerable number of publications dealt with lupeol and its analogues due to the interest in their pharmacological activities against cancer, inflammation, arthritis, diabetes, and heart disease. To identify further potential applications of lupeol and its analogues, it is necessary to investigate their mechanisms of action, particularly their interaction with off-target proteins that may trigger adverse effects or toxicity. In this study, we simulated and quantified the interaction of lupeol and 11 of its analogues toward a series of 16 proteins known or suspected to trigger adverse effects employing the VirtualToxLab. This software provides a thermodynamic estimate of the binding affinity, and the results were challenged by molecular-dynamics simulations, which allow probing the kinetic stability of the underlying protein–ligand complexes. Our results indicate that there is a moderate toxic potential for lupeol and some of its analogues, by targeting and binding to nuclear receptors involved in fertility, which could trigger undesired adverse effects.
- 13 July 2017
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 30 (8) , 1562-1571
In Silico Prediction of the Toxic Potential of Lupeol
Lupeol is a natural triterpenoid found in many plant species such as mango. This compound is the principal active component of many traditional herbal medicines. In the past decade, a considerable number of publications dealt with lupeol and its analogues due to the interest in their pharmacological activities against cancer, inflammation, arthritis, diabetes, and heart disease. To identify further potential applications of lupeol and its analogues, it is necessary to investigate their mechanisms of action, particularly their interaction with off-target proteins that may trigger adverse effects or toxicity. In this study, we simulated and quantified the interaction of lupeol and 11 of its analogues toward a series of 16 proteins known or suspected to trigger adverse effects employing the VirtualToxLab. This software provides a thermodynamic estimate of the binding affinity, and the results were challenged by molecular-dynamics simulations, which allow probing the kinetic stability of the underlying protein–ligand complexes. Our results indicate that there is a moderate toxic potential for lupeol and some of its analogues, by targeting and binding to nuclear receptors involved in fertility, which could trigger undesired adverse effects.
- Open Access
- 30 November 2016
- Published by Forschungsgesellschaft für Arbeitsphysiologie und Arbeitsschutz e.V. in EXCLI Journal
- Vol. 15, 758-771
Lupane-type triterpenes and their anti-cancer activities against most common malignant tumors: A review
In recent times, a great deal of interest has been motivated on plant derived compounds known as nutraceuticals. These compounds exert important beneficial activities that improve people's health status when are consumed regularly, and now they appear as a viable option to explore their possible therapeutic effects against diseases like cancer. Particularly, lupane-type triterpenes have shown great ability to modulate multiple cancer-related signaling pathways and processes, including NF-κB, Wnt/β-catenin, PI3K/Akt, apoptosis, and many other routes related to proliferation or cell death, which are uncontrolled in malignant tumors. These investigations have promoted in vitro and in vivo studies, searching their mechanisms of action; although more research is still needed to prove its potential in human clinical trials. This review focuses on the ability of betulin, betulinic acid and lupeol to show benefits against the most common types of malignant tumors, which are considered a major global threat for public health.
- 30 November 2016
- Published by Forschungsgesellschaft für Arbeitsphysiologie und Arbeitsschutz e.V. in EXCLI Journal
- Vol. 15, 758-771
Open AccessLupane-type triterpenes and their anti-cancer activities against most common malignant tumors: A review
In recent times, a great deal of interest has been motivated on plant derived compounds known as nutraceuticals. These compounds exert important beneficial activities that improve people's health status when are consumed regularly, and now they appear as a viable option to explore their possible therapeutic effects against diseases like cancer. Particularly, lupane-type triterpenes have shown great ability to modulate multiple cancer-related signaling pathways and processes, including NF-κB, Wnt/β-catenin, PI3K/Akt, apoptosis, and many other routes related to proliferation or cell death, which are uncontrolled in malignant tumors. These investigations have promoted in vitro and in vivo studies, searching their mechanisms of action; although more research is still needed to prove its potential in human clinical trials. This review focuses on the ability of betulin, betulinic acid and lupeol to show benefits against the most common types of malignant tumors, which are considered a major global threat for public health.
- 1 December 2015
- Published by Elsevier in Industrial Crops and Products
- Vol. 77, 827-832
Isolation of lupeol from white oak leaves and its anti-inflammatory activity
- 1 December 2015
- Published by Elsevier in Industrial Crops and Products
- Vol. 77, 827-832
Isolation of lupeol from white oak leaves and its anti-inflammatory activity
- 1 November 2015
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 85, 2-9
Morphological and release characterization of nanoparticles formulated with poly (dl-lactide-co-glycolide) (PLGA) and lupeol: In vitro permeability and modulator effect on NF-κB in Caco-2 cell system stimulated with TNF-α
- 1 November 2015
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 85, 2-9
Morphological and release characterization of nanoparticles formulated with poly (dl-lactide-co-glycolide) (PLGA) and lupeol: In vitro permeability and modulator effect on NF-κB in Caco-2 cell system stimulated with TNF-α